A Study of Axicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

Completed

Plain-English translation of NCT03105336 on ClinicalTrials.gov ↗ · Source last updated December 2025 · How we translate trials

Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.

Trial locations(19 sites)

United States

Banner MD Anderson Cancer Center, Gilbert, Arizona

USC Norris Comprehensive Cancer Center, Los Angeles, California

University of California Los Angeles, Los Angeles, California

Georgetown Lombardi Comprehensive Cancer Center, Washington D.C., District of Columbia

University of Miami Hospital and Clinics, Miami, Florida